Table 1. Baseline characteristics of study participants (N=102).
| Characteristics | n (%) |
| ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2. | |
Age (year) (
 )
|
50.5±8.7 |
| Marital status | |
| Married | 93 (91.2) |
| Divorced | 4 (3.9) |
| Widowed | 5 (4.9) |
| Educational level (year) | |
| ≤9 | 18 (17.6) |
| >9 | 84 (82.4) |
| Occupational status | |
| Farmer | 9 (8.8) |
| Worker | 21 (20.6) |
| Office worker | 27 (26.5) |
| Professional skill worker | 20 (19.6) |
| Individual business | 2 (2.0) |
| Unemployed | 2 (2.0) |
| Other | 21 (20.6) |
| Type of adjuvant therapy received | |
| Surgery | 102 (100) |
| Chemotherapy | 59 (57.8) |
| Endocrine therapy | 62 (60.8) |
| ER and PR status | |
| ER+ | 78 (76.5) |
| ER− | 23 (22.5) |
| PR+ | 77 (75.5) |
| PR− | 24 (23.5) |
| HER2 status | |
| HER2+ | 79 (77.5) |
| HER2++ | 8 (7.8) |
| HER2+++ | 14 (13.7) |